Report Overview

  1. Submitted URL

    t.dripemail2.com/c/eyJhbGciOiJIUzI1NiJ9.eyJhdWQiOiJkZXRvdXIiLCJpc3MiOiJtb25vbGl0aCIsInN1YiI6ImRldG91cl9saW5rIiwiaWF0IjoxNzE1MzEyNzI0LCJuYmYiOjE3MTUzMTI3MjQsImFjY291bnRfaWQiOiI2MTU3NjEzIiwiZGVsaXZlcnlfaWQiOiI2c2dybHcyeTRqdDRibzJucXY1dSIsInVybCI6Imh0dHBzOi8vYmlvcGhhcm1hYXBhYy5jb20vY29tcGFueS1yZXN1bHRzLzEyMC80NzU0L2Nlby1tYXR0LWZvZWhyLWFubm91bmNlcy1vbW5pYWJzLXN0cm9uZy1zdGFydC1pbi0yMDI0LXdpdGgtbmV3LXBhcnRuZXJzaGlwcy1hbmQtZXhwYW5kZWQtcG9ydGZvbGlvLmh0bWw_X19zPTczcmxzd213MXpzcW94cjd5eTYwJnV0bV9zb3VyY2U9ZHJpcCZ1dG1fbWVkaXVtPWVtYWlsJnV0bV9jYW1wYWlnbj1DRU8rTWF0dCtGb2VocitBbm5vdW5jZXMrT21uaUFiJTI3cytTdHJvbmcrU3RhcnQraW4rMjAyNCt3aXRoK05ldytQYXJ0bmVyc2hpcHMrYW5kK0V4cGFuZGVkK1BvcnRmb2xpbyJ9.3YPmRTRoAONSUTfftsUzdSL8NgGwc6PG0hBSmk8CjuM

  2. IP

    34.233.151.134

    ASN

    #14618 AMAZON-AES

  3. Submitted

    2024-05-10 07:58:34

    Access

    public

  4. Website Title

    Checking your browser before accessing. Just a moment...

  5. Final URL

    biopharmaapac.com/company-results/120/4754/ceo-matt-foehr-announces-omniabs-strong-start-in-2024-with-new-partnerships-and-expanded-portfolio.html?__s=73rlswmw1zsqoxr7yy60&utm_source=drip&utm_medium=email&utm_campaign=CEO+Matt+Foehr+Announces+OmniAb%27s+Strong+Start+in+2024+with+New+Partnerships+and+Expanded+Portfolio

  6. Tags

  7. urlquery detections

    No alerts detected

Detections

  1. urlquery

    0

  2. Network Intrusion Detection

    2

  3. Threat Detection Systems

    0

Domain Summary

Domain / FQDNRankRegisteredFirst SeenLast Seen
t.dripemail2.com1232342013-11-182014-05-172024-05-02
biopharmaapac.comunknown2020-11-232021-04-032024-03-21

Related reports

Network Intrusion Detection Systems

Suricata /w Emerging Threats Pro

SeveritySource IPDestination IPAlert
low 86.110.225.202Client IP
low 86.110.225.202Client IP

Threat Detection Systems

Public InfoSec YARA rules

No alerts detected


OpenPhish

No alerts detected


PhishTank

No alerts detected


mnemonic secure dns

No alerts detected


Quad9 DNS

No alerts detected


ThreatFox

No alerts detected


JavaScript (4)

HTTP Transactions (35)

URLIPResponseSize
t.dripemail2.com/c/eyJhbGciOiJIUzI1NiJ9.eyJhdWQiOiJkZXRvdXIiLCJpc3MiOiJtb25vbGl0aCIsInN1YiI6ImRldG91cl9saW5rIiwiaWF0IjoxNzE1MzEyNzI0LCJuYmYiOjE3MTUzMTI3MjQsImFjY291bnRfaWQiOiI2MTU3NjEzIiwiZGVsaXZlcnlfaWQiOiI2c2dybHcyeTRqdDRibzJucXY1dSIsInVybCI6Imh0dHBzOi8vYmlvcGhhcm1hYXBhYy5jb20vY29tcGFueS1yZXN1bHRzLzEyMC80NzU0L2Nlby1tYXR0LWZvZWhyLWFubm91bmNlcy1vbW5pYWJzLXN0cm9uZy1zdGFydC1pbi0yMDI0LXdpdGgtbmV3LXBhcnRuZXJzaGlwcy1hbmQtZXhwYW5kZWQtcG9ydGZvbGlvLmh0bWw_X19zPTczcmxzd213MXpzcW94cjd5eTYwJnV0bV9zb3VyY2U9ZHJpcCZ1dG1fbWVkaXVtPWVtYWlsJnV0bV9jYW1wYWlnbj1DRU8rTWF0dCtGb2VocitBbm5vdW5jZXMrT21uaUFiJTI3cytTdHJvbmcrU3RhcnQraW4rMjAyNCt3aXRoK05ldytQYXJ0bmVyc2hpcHMrYW5kK0V4cGFuZGVkK1BvcnRmb2xpbyJ9.3YPmRTRoAONSUTfftsUzdSL8NgGwc6PG0hBSmk8CjuM
52.203.141.27 0 B
biopharmaapac.com/company-results/120/4754/ceo-matt-foehr-announces-omniabs-strong-start-in-2024-with-new-partnerships-and-expanded-portfolio.html?__s=73rlswmw1zsqoxr7yy60&utm_source=drip&utm_medium=email&utm_campaign=CEO+Matt+Foehr+Announces+OmniAb%27s+Strong+Start+in+2024+with+New+Partnerships+and+Expanded+Portfolio
154.41.248.23403 Forbidden2.2 kB
biopharmaapac.com/company-results/120/4754/ceo-matt-foehr-announces-omniabs-strong-start-in-2024-with-new-partnerships-and-expanded-portfolio.html?__s=73rlswmw1zsqoxr7yy60&utm_source=drip&utm_medium=email&utm_campaign=CEO+Matt+Foehr+Announces+OmniAb%27s+Strong+Start+in+2024+with+New+Partnerships+and+Expanded+Portfolio
154.41.248.23403 Forbidden2.4 kB
biopharmaapac.com/hcdn-cgi/jschallenge
154.41.248.23200 OK334 B
biopharmaapac.com/favicon.ico
154.41.248.23403 Forbidden2.4 kB
biopharmaapac.com/hcdn-cgi/jschallenge-validate
154.41.248.23 0 B
biopharmaapac.com/company-results/120/4754/ceo-matt-foehr-announces-omniabs-strong-start-in-2024-with-new-partnerships-and-expanded-portfolio.html?__s=73rlswmw1zsqoxr7yy60&utm_source=drip&utm_medium=email&utm_campaign=CEO+Matt+Foehr+Announces+OmniAb%27s+Strong+Start+in+2024+with+New+Partnerships+and+Expanded+Portfolio
154.41.248.23403 Forbidden2.2 kB
biopharmaapac.com/company-results/120/4754/ceo-matt-foehr-announces-omniabs-strong-start-in-2024-with-new-partnerships-and-expanded-portfolio.html?__s=73rlswmw1zsqoxr7yy60&utm_source=drip&utm_medium=email&utm_campaign=CEO+Matt+Foehr+Announces+OmniAb%27s+Strong+Start+in+2024+with+New+Partnerships+and+Expanded+Portfolio
154.41.248.23403 Forbidden2.4 kB
biopharmaapac.com/hcdn-cgi/jschallenge
154.41.248.23200 OK334 B
biopharmaapac.com/favicon.ico
154.41.248.23403 Forbidden2.4 kB
biopharmaapac.com/hcdn-cgi/jschallenge-validate
154.41.248.23 0 B
biopharmaapac.com/company-results/120/4754/ceo-matt-foehr-announces-omniabs-strong-start-in-2024-with-new-partnerships-and-expanded-portfolio.html?__s=73rlswmw1zsqoxr7yy60&utm_source=drip&utm_medium=email&utm_campaign=CEO+Matt+Foehr+Announces+OmniAb%27s+Strong+Start+in+2024+with+New+Partnerships+and+Expanded+Portfolio
154.41.248.23403 Forbidden2.2 kB
biopharmaapac.com/company-results/120/4754/ceo-matt-foehr-announces-omniabs-strong-start-in-2024-with-new-partnerships-and-expanded-portfolio.html?__s=73rlswmw1zsqoxr7yy60&utm_source=drip&utm_medium=email&utm_campaign=CEO+Matt+Foehr+Announces+OmniAb%27s+Strong+Start+in+2024+with+New+Partnerships+and+Expanded+Portfolio
154.41.248.23403 Forbidden2.4 kB
biopharmaapac.com/hcdn-cgi/jschallenge
154.41.248.23200 OK334 B
biopharmaapac.com/favicon.ico
154.41.248.23403 Forbidden2.4 kB
biopharmaapac.com/hcdn-cgi/jschallenge-validate
154.41.248.23 0 B
biopharmaapac.com/company-results/120/4754/ceo-matt-foehr-announces-omniabs-strong-start-in-2024-with-new-partnerships-and-expanded-portfolio.html?__s=73rlswmw1zsqoxr7yy60&utm_source=drip&utm_medium=email&utm_campaign=CEO+Matt+Foehr+Announces+OmniAb%27s+Strong+Start+in+2024+with+New+Partnerships+and+Expanded+Portfolio
154.41.248.23403 Forbidden2.2 kB
biopharmaapac.com/company-results/120/4754/ceo-matt-foehr-announces-omniabs-strong-start-in-2024-with-new-partnerships-and-expanded-portfolio.html?__s=73rlswmw1zsqoxr7yy60&utm_source=drip&utm_medium=email&utm_campaign=CEO+Matt+Foehr+Announces+OmniAb%27s+Strong+Start+in+2024+with+New+Partnerships+and+Expanded+Portfolio
154.41.248.23403 Forbidden2.4 kB
biopharmaapac.com/hcdn-cgi/jschallenge
154.41.248.23200 OK334 B
biopharmaapac.com/favicon.ico
154.41.248.23403 Forbidden2.4 kB
biopharmaapac.com/hcdn-cgi/jschallenge-validate
154.41.248.23 0 B
biopharmaapac.com/company-results/120/4754/ceo-matt-foehr-announces-omniabs-strong-start-in-2024-with-new-partnerships-and-expanded-portfolio.html?__s=73rlswmw1zsqoxr7yy60&utm_source=drip&utm_medium=email&utm_campaign=CEO+Matt+Foehr+Announces+OmniAb%27s+Strong+Start+in+2024+with+New+Partnerships+and+Expanded+Portfolio
154.41.248.23403 Forbidden2.2 kB
biopharmaapac.com/company-results/120/4754/ceo-matt-foehr-announces-omniabs-strong-start-in-2024-with-new-partnerships-and-expanded-portfolio.html?__s=73rlswmw1zsqoxr7yy60&utm_source=drip&utm_medium=email&utm_campaign=CEO+Matt+Foehr+Announces+OmniAb%27s+Strong+Start+in+2024+with+New+Partnerships+and+Expanded+Portfolio
154.41.248.23403 Forbidden2.4 kB
biopharmaapac.com/hcdn-cgi/jschallenge
154.41.248.23200 OK334 B
biopharmaapac.com/favicon.ico
154.41.248.23403 Forbidden2.4 kB
biopharmaapac.com/hcdn-cgi/jschallenge-validate
154.41.248.23 0 B
biopharmaapac.com/company-results/120/4754/ceo-matt-foehr-announces-omniabs-strong-start-in-2024-with-new-partnerships-and-expanded-portfolio.html?__s=73rlswmw1zsqoxr7yy60&utm_source=drip&utm_medium=email&utm_campaign=CEO+Matt+Foehr+Announces+OmniAb%27s+Strong+Start+in+2024+with+New+Partnerships+and+Expanded+Portfolio
154.41.248.23403 Forbidden2.2 kB
biopharmaapac.com/company-results/120/4754/ceo-matt-foehr-announces-omniabs-strong-start-in-2024-with-new-partnerships-and-expanded-portfolio.html?__s=73rlswmw1zsqoxr7yy60&utm_source=drip&utm_medium=email&utm_campaign=CEO+Matt+Foehr+Announces+OmniAb%27s+Strong+Start+in+2024+with+New+Partnerships+and+Expanded+Portfolio
154.41.248.23403 Forbidden2.4 kB
biopharmaapac.com/hcdn-cgi/jschallenge
154.41.248.23200 OK334 B
biopharmaapac.com/favicon.ico
154.41.248.23403 Forbidden2.4 kB
biopharmaapac.com/hcdn-cgi/jschallenge-validate
154.41.248.23 0 B
biopharmaapac.com/company-results/120/4754/ceo-matt-foehr-announces-omniabs-strong-start-in-2024-with-new-partnerships-and-expanded-portfolio.html?__s=73rlswmw1zsqoxr7yy60&utm_source=drip&utm_medium=email&utm_campaign=CEO+Matt+Foehr+Announces+OmniAb%27s+Strong+Start+in+2024+with+New+Partnerships+and+Expanded+Portfolio
154.41.248.23403 Forbidden2.2 kB
biopharmaapac.com/company-results/120/4754/ceo-matt-foehr-announces-omniabs-strong-start-in-2024-with-new-partnerships-and-expanded-portfolio.html?__s=73rlswmw1zsqoxr7yy60&utm_source=drip&utm_medium=email&utm_campaign=CEO+Matt+Foehr+Announces+OmniAb%27s+Strong+Start+in+2024+with+New+Partnerships+and+Expanded+Portfolio
154.41.248.23403 Forbidden2.4 kB
biopharmaapac.com/hcdn-cgi/jschallenge
154.41.248.23200 OK334 B
biopharmaapac.com/favicon.ico
154.41.248.23403 Forbidden2.4 kB